Yahui Long: Obtained registration certificate for hepatitis B test reagents.

Announcement from Yahui Long: The company recently received a medical device registration certificate issued by the National Medical Products Administration, involving hepatitis B virus e antigen and e antibody detection reagents. The registration certificate is valid until April 28, 2030, and the product is used for quantitative determination of hepatitis B virus-related antigens and antibodies in human serum or plasma, clinically used for auxiliary diagnosis of hepatitis B virus infection. As of now, the company has obtained 171 domestic registration certificates for luminous reagents. The acquisition of this registration certificate will further enrich the company's fully automated chemiluminescence product line and enhance its detection capabilities in the field of infection.